Immediate Impact
3 from Science/Nature 64 standout
Citing Papers
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
Fluorescent dyes based on rhodamine derivatives for bioimaging and therapeutics: recent progress, challenges, and prospects
2023 Standout
Works of Nigel McCracken being referenced
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer
2023
The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Nigel McCracken | 177 | 72 | 82 | 150 | 123 | 25 | 579 | |
| C.-W. Chi | 236 | 81 | 48 | 75 | 67 | 30 | 682 | |
| Hongyan Li | 219 | 75 | 55 | 115 | 89 | 28 | 616 | |
| B Brennan | 106 | 152 | 51 | 138 | 73 | 14 | 566 | |
| Peter D. Gorycki | 342 | 166 | 75 | 103 | 63 | 29 | 726 | |
| Stacy L. Gelhaus | 206 | 38 | 29 | 176 | 65 | 17 | 532 | |
| Toshihiro Asai | 210 | 47 | 31 | 42 | 114 | 21 | 644 | |
| Ejaife O. Agbani | 129 | 38 | 24 | 43 | 98 | 34 | 681 | |
| Amanda Freeman | 176 | 282 | 178 | 102 | 95 | 12 | 711 | |
| A Thalén | 76 | 17 | 42 | 170 | 124 | 16 | 535 | |
| Parnian Zia‐Amirhosseini | 139 | 108 | 70 | 251 | 174 | 18 | 732 |
All Works
Loading papers...